Literature DB >> 20854094

Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study.

Cara East1, Benjamin L Willis, Carolyn E Barlow, Bruce D Grannemann, Shannon J FitzGerald, Laura F DeFina, Madhukar H Trivedi.   

Abstract

BACKGROUND: Depression, metabolic syndrome, and reduced cardiorespiratory fitness (CRF) are known to increase the risk of developing diabetes and cardiovascular disease. The association among these factors in a generally healthy, active population with access to health care is not well defined.
METHODS: This was a cross-sectional analysis of data collected on 5,125 women and men during preventive care examinations at the Cooper Clinic from 2000 to 2008. The main outcome measures were depressive symptoms as assessed by the Centers for Epidemiologic Studies Depression Scale short form (CES-D-10) questionnaire, presence or absence of metabolic syndrome, and CRF as measured by a maximal exercise treadmill test.
RESULTS: Women and men who exhibited depressive symptoms had a statistically higher prevalence of metabolic syndrome compared to those who did not (for women, 15.4% versus 7.2%, P < 0.0001; for men, 31.6% versus 22.8%, P < 0.0001). Individuals with depressive symptoms had an increased frequency of higher waist circumference, higher triglycerides, and lower high-density lipoprotein. Women with depressive symptoms also had marginally higher fasting blood glucose levels. After adjusting for age and smoking status, the odds of metabolic syndrome in women with depressive symptoms was 2.81 [95% confidence interval (CI), 2.01-3.93] times the odds of metabolic syndrome in those without depressive symptoms, and in men with depressive symptoms, the odds were 1.69 (95% CI, 1.42-2.00) times the odds of metabolic syndrome in men without. When controlled for CRF level, the presence or absence of depressive symptoms on the presence of metabolic syndrome is attenuated but remains statistically significant in women.
CONCLUSION: Even in a generally healthy population with access to health care, the presence of depressive symptoms was associated with increased metabolic syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20854094     DOI: 10.1089/met.2010.0017

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  11 in total

1.  Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement?

Authors:  Ronette L Kolotkin; Kishore M Gadde; Craig A Peterson; Ross D Crosby
Journal:  Qual Life Res       Date:  2015-10-07       Impact factor: 4.147

Review 2.  Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies.

Authors:  An Pan; Nana Keum; Olivia I Okereke; Qi Sun; Mika Kivimaki; Richard R Rubin; Frank B Hu
Journal:  Diabetes Care       Date:  2012-05       Impact factor: 19.112

3.  Association between depressive symptoms and metabolic syndrome in police officers: results from two cross-sectional studies.

Authors:  Tara A Hartley; Sarah S Knox; Desta Fekedulegn; Celestina Barbosa-Leiker; John M Violanti; Michael E Andrew; Cecil M Burchfiel
Journal:  J Environ Public Health       Date:  2012-01-18

4.  Prevalence of Metabolic Syndrome among nursing personnel and its association with occupational stress, anxiety and depression.

Authors:  Renata Perfeito Ribeiro; Maria Helena Palucci Marziale; Julia Trevisan Martins; Patrícia Helena Vivan Ribeiro; Maria Lucia do Carmo Cruz Robazzi; José Carlos Dalmas
Journal:  Rev Lat Am Enfermagem       Date:  2015-07-03

5.  Prevalence of metabolic syndrome and its association with depression in patients with schizophrenia.

Authors:  Sirijit Suttajit; Sutrak Pilakanta
Journal:  Neuropsychiatr Dis Treat       Date:  2013-07-09       Impact factor: 2.570

6.  Sex Differences in Associations of Depressive Symptoms with Cardiovascular Risk Factors and Metabolic Syndrome among African Americans.

Authors:  Denise C Cooper; Ranak B Trivedi; Karin M Nelson; Gayle E Reiber; Alan B Zonderman; Michele K Evans; Shari R Waldstein
Journal:  Cardiovasc Psychiatry Neurol       Date:  2013-09-16

7.  The relationship between depression and risk of metabolic syndrome: a meta-analysis of observational studies.

Authors:  Yousef Moradi; Ahmed N Albatineh; Hassan Mahmoodi; Reza Ghanei Gheshlagh
Journal:  Clin Diabetes Endocrinol       Date:  2021-03-02

8.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

9.  Metabolic Syndrome in Drug-naïve Patients with Depressive Disorders.

Authors:  Sandeep Grover; Naresh Nebhinani; Subho Chakrabarti; Ajit Avasthi; Parmanand Kulhara
Journal:  Indian J Psychol Med       Date:  2013-04

10.  Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study.

Authors:  Atsuko Sekita; Hisatomi Arima; Toshiharu Ninomiya; Tomoyuki Ohara; Yasufumi Doi; Yoichiro Hirakawa; Masayo Fukuhara; Jun Hata; Koji Yonemoto; Yukiko Ga; Takanari Kitazono; Shigenobu Kanba; Yutaka Kiyohara
Journal:  BMC Public Health       Date:  2013-09-18       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.